30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Eckelman Brendan P.

Track

Insider profile

Performance

Overall performance
3.3
Performance over holding periods
3.3
30 days 90 days 120 days
Average return 59% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Eckelman Brendan P.'s trades of Inhibrx Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-05-30 2024-05-28
US Inhibrx Inc (INBX)
S Sale
99,739 -11.5%
156.15
US$2,972,701 		99,739 -11.5% 156.15 US$2,972,701
2024-05-28 2024-05-28
US Inhibrx Inc (INBX)
PrS Proposed sale
60,550
311.13
US$1,482,791 		60,550 311.13 US$1,482,791
2024-05-22 2024-05-22
US Inhibrx Inc (INBX)
PrS Proposed sale
38,185
294.43
US$860,179 		38,185 294.43 US$860,179
2024-03-13 2024-03-13
US Inhibrx Inc (INBX)
PrS Proposed sale
1,898
35.33
US$67,062 		1,898 35.33 US$67,062
2024-03-12 2024-03-12
US Inhibrx Inc (INBX)
PrS Proposed sale
24,050
35.25
US$847,856 		24,050 35.25 US$847,856
2024-03-11 2024-03-11
US Inhibrx Inc (INBX)
PrS Proposed sale
13,558
35.32
US$478,827 		13,558 35.32 US$478,827
2024-03-08 2024-03-08
US Inhibrx Inc (INBX)
PrS Proposed sale
2,150
35.75
US$76,862 		2,150 35.75 US$76,862
2023-03-02 2023-03-01
US Inhibrx Inc (INBX)
PlS Planned sale
400 -0.0%
24.71
US$9,883 		400 -0.0% 24.71 US$9,883
2023-03-02 2023-03-01
US Inhibrx Inc (INBX)
PlS Planned sale
39,600 -1.9%
24.20
US$958,348 		39,600 -1.9% 24.20 US$958,348
2023-02-02 2023-02-02
US Inhibrx Inc (INBX)
PlS Planned sale
1,130 -0.1%
25.89
US$29,261 		1,130 -0.1% 25.89 US$29,261
2023-02-02 2023-02-02
US Inhibrx Inc (INBX)
PlS Planned sale
10,120 -0.5%
25.40
US$257,094 		10,120 -0.5% 25.40 US$257,094
2023-02-02 2023-02-01
US Inhibrx Inc (INBX)
PlS Planned sale
693 -0.0%
25.66
US$17,780 		693 -0.0% 25.66 US$17,780
2023-02-02 2023-02-01
US Inhibrx Inc (INBX)
PlS Planned sale
14,608 -0.7%
25.08
US$366,366 		14,608 -0.7% 25.08 US$366,366
2023-02-02 2023-02-01
US Inhibrx Inc (INBX)
PlS Planned sale
13,449 -0.6%
24.29
US$326,710 		13,449 -0.6% 24.29 US$326,710
2023-01-04 2023-01-04
US Inhibrx Inc (INBX)
PlS Planned sale
3,003 -0.1%
23.99
US$72,043 		3,003 -0.1% 23.99 US$72,043
2023-01-04 2023-01-04
US Inhibrx Inc (INBX)
PlS Planned sale
4,102 -0.2%
23.11
US$94,786 		4,102 -0.2% 23.11 US$94,786
2023-01-04 2023-01-03
US Inhibrx Inc (INBX)
PlS Planned sale
2,084 -0.1%
25.09
US$52,293 		2,084 -0.1% 25.09 US$52,293
2023-01-04 2023-01-03
US Inhibrx Inc (INBX)
PlS Planned sale
8,598 -0.4%
24.36
US$209,426 		8,598 -0.4% 24.36 US$209,426
2023-01-04 2023-01-03
US Inhibrx Inc (INBX)
PlS Planned sale
22,213 -1.0%
23.41
US$520,051 		22,213 -1.0% 23.41 US$520,051
2022-12-07 2022-12-06
US Inhibrx Inc (INBX)
PlS Planned sale
1,392 -0.1%
28.46
US$39,617 		1,392 -0.1% 28.46 US$39,617
2022-12-07 2022-12-06
US Inhibrx Inc (INBX)
PlS Planned sale
17,681 -0.8%
27.57
US$487,493 		17,681 -0.8% 27.57 US$487,493
2022-12-07 2022-12-06
US Inhibrx Inc (INBX)
PlS Planned sale
20,927 -1.0%
26.83
US$561,572 		20,927 -1.0% 26.83 US$561,572
2022-11-02 2022-11-01
US Inhibrx Inc (INBX)
PlS Planned sale
12,349 -0.6%
33.90
US$418,641 		12,349 -0.6% 33.90 US$418,641
2022-11-02 2022-11-01
US Inhibrx Inc (INBX)
PlS Planned sale
27,651 -1.2%
33.34
US$921,746 		27,651 -1.2% 33.34 US$921,746
2022-10-05 2022-10-04
US Inhibrx Inc (INBX)
PlS Planned sale
100 -0.0%
30.52
US$3,052 		100 -0.0% 30.52 US$3,052
2022-10-05 2022-10-04
US Inhibrx Inc (INBX)
PlS Planned sale
10,893 -0.5%
29.68
US$323,302 		10,893 -0.5% 29.68 US$323,302
2022-10-05 2022-10-04
US Inhibrx Inc (INBX)
PlS Planned sale
5,954 -0.3%
28.97
US$172,495 		5,954 -0.3% 28.97 US$172,495
2022-10-05 2022-10-04
US Inhibrx Inc (INBX)
PlS Planned sale
4,262 -0.2%
27.76
US$118,299 		4,262 -0.2% 27.76 US$118,299
2022-10-05 2022-10-04
US Inhibrx Inc (INBX)
PlS Planned sale
11,136 -0.5%
26.78
US$298,182 		11,136 -0.5% 26.78 US$298,182
2022-10-05 2022-10-04
US Inhibrx Inc (INBX)
PlS Planned sale
6,207 -0.3%
26.06
US$161,763 		6,207 -0.3% 26.06 US$161,763
2022-10-05 2022-10-04
US Inhibrx Inc (INBX)
PlS Planned sale
1,448 -0.1%
24.67
US$35,720 		1,448 -0.1% 24.67 US$35,720
2022-09-07 2022-09-06
US Inhibrx Inc (INBX)
PlS Planned sale
2,493 -0.1%
15.66
US$39,032 		2,493 -0.1% 15.66 US$39,032
2022-09-07 2022-09-06
US Inhibrx Inc (INBX)
PlS Planned sale
37,507 -1.5%
14.86
US$557,241 		37,507 -1.5% 14.86 US$557,241
2022-08-04 2022-08-03
US Inhibrx Inc (INBX)
PlS Planned sale
15,500 -0.6%
18.47
US$286,209 		15,500 -0.6% 18.47 US$286,209
2022-08-04 2022-08-02
US Inhibrx Inc (INBX)
PlS Planned sale
24,500 -1.0%
17.70
US$433,626 		24,500 -1.0% 17.70 US$433,626
2022-07-08 2022-07-07
US Inhibrx Inc (INBX)
PlS Planned sale
40,000 -1.6%
17.17
US$686,800 		40,000 -1.6% 17.17 US$686,800
2022-04-07 2022-04-05
US Inhibrx Inc (INBX)
PlS Planned sale
400 -0.0%
25.04
US$10,016 		400 -0.0% 25.04 US$10,016
2021-03-24 2021-03-24
US Inhibrx Inc (INBX)
PlS Planned sale
17,000 -0.7%
19.02
US$323,340 		17,000 -0.7% 19.02 US$323,340
2021-02-18 2021-02-16
US Inhibrx Inc (INBX)
PlS Planned sale
17,000 -0.7%
25.90
US$440,300 		17,000 -0.7% 25.90 US$440,300